Adicet Bio, Inc. — Director's Dealing 2022

Sep 13, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2022-09-09

Reporting Person: Schor Chen (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-09-09	Common Stock	S	8094	$16.5062	Disposed	66747	Indirect
2022-09-12	Common Stock	S	66747	$16.7694	Disposed	0	Indirect
2022-09-12	Common Stock	S	200	$18.00	Disposed	143060	Indirect
2022-09-13	Common Stock	S	3371	$18.0105	Disposed	139689	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	122712	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $16.50 to $16.56, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Securities and Exchange Commission ("SEC") staff upon request.

F3: Represents shares held directly by The I. Schor IRRV Trust, an irrevocable family trust having an independent trustee.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $16.50 to $16.96, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F5: Represents shares held directly by The C. Schor IRRV Trust, an irrevocable family trust having an independent trustee.

F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $18.00 to $18.05, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.